[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336852-105":59,"doc-detail-336852-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","characterization-of-a-ferroptosis-related-gene-signature-predicting-survival-and-immunotherapeutic-response-in-lung-adenocarcinoma","Characterization of a ferroptosis-related gene signature predicting survival and immunotherapeutic response in lung adenocarcinoma","","Lung cancer remains the leading cause of cancer-related mortality worldwide, and treatment failure driven by drug resistance limits survival and clinical outcomes. This study uses RNA-seq data from TCGA and GEO to construct and validate a ferroptosis-related gene signature for lung adenocarcinoma. The signature stratifies patients into high- and low-risk groups with significantly different survival. It is further linked to tumor mutation burden, microsatellite instability, and immune checkpoint blockade response, and identifies four candidate oncogenes via in silico and experimental validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/characterization-of-a-ferroptosis-related-gene-signature-predicting-survival-and-immunotherapeutic-response-in-lung-adenocarcinoma/336852/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/characterization-of-a-ferroptosis-related-gene-signature-predicting-survival-and-immunotherapeutic-response-in-lung-adenocarcinoma/336852.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the ferroptosis-related gene signature address in lung adenocarcinoma?","Question",{"text":112,"@type":113},"It aims to predict patient survival and treatment-related drug response, particularly in the context of drug resistance that worsens prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the gene signature constructed and validated?",{"text":117,"@type":113},"The study integrated RNA sequencing data from TCGA and GEO, identified a ferroptosis-related gene set, and then validated the resulting signature in a validation set and two external cohorts.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical associations were found for the high-risk versus low-risk groups?",{"text":121,"@type":113},"The high-risk group showed reduced survival compared with the low-risk group, and the signature correlated with tumor mutation burden, microsatellite instability, and response to immune checkpoint blockade.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336852,1790198345,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 18  \nResearch Paper  \nCharacterization of a ferroptosis-related gene signature predicting survival and immunotherapeutic response in lung adenocarcinoma  \nChuan Zhang1,*, Yingying Su2,*, Hongrui Wang3, Dan Dang4, Xin Huang3, Shuyou Shi3, Yue Shi5, Peng Zhang6, Ming Yang3  \n1 Department of Pediatric Surgery, The First Hospital of Jilin University, Changchun, China 2 Department of Anatomy, College of Basic Medical Sciences, Jilin University, Jilin, China  \n3 Department of Molecular Biology, College of Basic Medical Sciences, Jilin University, Changchun, China 4 Department of Neonatology, The First Hospital of Jilin University, Changchun, China  \n5 Department of Microbiology and Immunology, Changchun University of Chinese Medicine, Changchun, China 6 Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China  \n*Equal contribution  \nCorrespondence to: Peng Zhang, Ming Yang; email: [zhangpengjdyy@jlu.edu.cn](zhangpengjdyy@jlu.edu.cn), [myang48@jlu.edu.cn](myang48@jlu.edu.cn)[ ](myang48@jlu.edu.cn)[Keywords:](Keywords: lung adenocarcinoma)[ lung adenocarcinoma](Keywords: lung adenocarcinoma), [ferroptosis](ferroptosis), prognosis, drug response, gene signature  \nReceived: July 4, 2023 Accepted: July 11, 2024 Published: September 18, 2024  \nCopyright: © 2024 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nLung cancer remains the leading cause of cancer-related death worldwide, and drug resistance represents the main obstacle responsible for the poor mortality and prognosis. Here, to identify a novel gene signature for predicting survival and drug response, we jointly investigated RNA sequencing data of lung adenocarcinoma patients from TCGA and GEO databases, and identified a ferroptosis-related gene signature. The signature was validated in the validation set and two external cohorts. The high-risk group had a reduced survival than the low-risk group (P \u003C 0.05). Moreover, the established gene signature was associated with tumor mutation burden, microsatellite instability, and response to immune checkpoint blockade. In addition, four candidate oncogenes (RRM2, SLC2A1, DDIT4, and VDAC2) were identified to be candidate oncogenes using in silico and wet experiments, which could serve as potential therapeutic targets. Collectively, this study developed a novel ferroptosis-related gene signature for predicting prognosis and drug response, and identified four candidate oncogenes for lung adenocarcinoma.  \nINTRODUCTION  \nLung adenocarcinoma accounts for approximately 85% of pulmonary cancer [1] . The prognosis of advanced lung cancer is unsatisfactory owing to its heterogeneity [2, 3], with a five-year survival rate ranging from 4% to 17%[4] . Accurate prediction of patient survival is beneficial to clinical decision-making; nevertheless, there are limited tools to forecast the prognosis of lung adenocarcinoma [5] . Recently, integration of multiple biomarkers into a single signature has emerged to bean effective approach [6] . Therefore, the present study devoted to the development of a gene signature using  \nRNA sequencing data to predict the survival of lung adenocarcinoma.  \nDespite remarkable advances in tumor molecular targeted therapy and immunotherapy, the survival of lung adenocarcinoma remains undesirable due to the drug resistance. For instance, EGFR-TKIs can enhance progression-free survival compared to conventional chemotherapy in lung adenocarcinoma patients, while most patients eventually developed resistance to EGFR-TKIs [7] . Likewise, PD-1/PD-L1 blockade has emerged to be a promising immunotherapy, but still is hampered by drug resistance [8] . Collectively,  \n12608  \ntherapeutic resistance is a main challenge ","cbCaicAHJN0Bef6n","https://ap.wps.com/l/cbCaicAHJN0Bef6n","pdf",4238686,15,"English","# Abstract\n# Introduction\n# Results\n## Establishment of the prognostic ferroptosis-related gene signature","[{\"question\":\"What problem does the ferroptosis-related gene signature address in lung adenocarcinoma?\",\"answer\":\"It aims to predict patient survival and treatment-related drug response, particularly in the context of drug resistance that worsens prognosis.\"},{\"question\":\"How was the gene signature constructed and validated?\",\"answer\":\"The study integrated RNA sequencing data from TCGA and GEO, identified a ferroptosis-related gene set, and then validated the resulting signature in a validation set and two external cohorts.\"},{\"question\":\"What clinical associations were found for the high-risk versus low-risk groups?\",\"answer\":\"The high-risk group showed reduced survival compared with the low-risk group, and the signature correlated with tumor mutation burden, microsatellite instability, and response to immune checkpoint blockade.\"}]","Characterization of a ferroptosis-related gene signature predicting survival and immunotherapeutic response in lung adenocarcinoma | PDF",1790016867,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f2e241038bfbb078eee433eaeac0f9d.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9996b1392c0a3d7f37ae9f0cd9a7f24.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0a19ef94d27eb9782b0a53f167e1fe5.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b42d303b890a56aec8c6f9ff6c558feb.webp",980,1268]